EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial

Bom Lee, Seung-Jun Lee iD, Byeong-Keuk Kim iD, Yong-Joon Lee iD, Sung-Jin Hong iD, Chul-Min Ahn iD, Jung-Sun Kim iD, Young-Guk Ko iD, Donghoon Choi iD, Meyong-Ki Hong iD, Yangsoo Jang iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-06 · 43 (6)

DOI: 10.1161/atvbaha.122.318725 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-06. Verfasst von Bom Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea (B.L.,…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We sought to explore the sex differences in clinical outcomes among patients with acute coronary syndrome treated with ticagrelor monotherapy after ticagrelor-based 3-month versus 12-month dual-antiplatelet therapy.

Methods

This was a post hoc analysis of the TICO trial (Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus-Eluting Stent for Acute Coronary Syndrome; n=3056)—a randomized controlled trial for patients with acute coronary syndrome treated with drug-eluting stent. The primary outcome was a net adverse clinical event (composite of major bleeding, death, myocardial infarction, stent thrombosis, stroke, or target-vessel revascularization) 1 year after drug-eluting stent implantation. Secondary outcomes included major bleeding and major adverse cardiac and cerebrovascular events.

Results

There were 27.3% (n=628) women in the TICO trial; they were older with lower body mass index and higher prevalence of hypertension, diabetes, or chronic kidney disease than men. Compared with men, women had higher risk of net adverse clinical events (hazard ratio [HR], 1.89 [95% CI, 1.34–2.67]), major adverse cardiac and cerebrovascular events (HR, 1.69 [95% CI, 1.07–2.68]), and major bleeding (HR, 2.04 [95% CI, 1.25–3.35]). Among the groups stratified by sex and dual-antiplatelet therapy strategy, the incidences of primary and secondary outcomes were significantly different and the highest in women with ticagrelor-based 12-month dual-antiplatelet therapy ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeDrug-Eluting StentsPercutaneous Coronary InterventionHumansFemaleMaleAspirinTicagrelorPlatelet Aggregation InhibitorsSex CharacteristicsHemorrhage

Stichwörter der Autor:innen

drug-eluting stentsincidencesexthrombosisticagrelor

Substanzen

AspirinTicagrelorPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea (B.L., Y.J.).
  • Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea (S.-J.L., B.-K.K., Y.-J.L., S.-J.H., C.-M.A., J.-S.K., Y.-G.K., D.C.,…

ORCID-Profile: Seung-Jun Lee, Byeong-Keuk Kim, Yong-Joon Lee, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Meyong-Ki Hong, Yangsoo Jang

Zitieren

APA

Lee, B., Lee, S. J., Kim, B. K., Lee, Y. J., Hong, S. J., Ahn, C. M., Kim, J. S., Ko, Y. G., Choi, D., Hong, M. K., & Jang, Y. (2023). Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(6). https://doi.org/10.1161/atvbaha.122.318725

Vancouver

Lee B, Lee SJ, Kim BK, Lee YJ, Hong SJ, Ahn CM, et al. Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(6). doi:10.1161/atvbaha.122.318725

BibTeX
@article{Lee2023,
  author = {Lee, Bom and Lee, Seung-Jun and Kim, Byeong-Keuk and Lee, Yong-Joon and Hong, Sung-Jin and Ahn, Chul-Min and Kim, Jung-Sun and Ko, Young-Guk and Choi, Donghoon and Hong, Meyong-Ki and Jang, Yangsoo},
  title = {Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  volume = {43},
  number = {6},
  doi = {10.1161/atvbaha.122.318725}
}
Kostenlos starten →